Woodford Investment Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-11,350,719
| Closed | -$221M | – | 2 |
|
|
2019
Q3 | $221M | Sell |
11,350,719
-809,261
| -7% | -$15.8M | 71.3% | 1 |
|
|
2019
Q2 | $199M | Sell |
12,159,980
-1,219,999
| -9% | -$19.9M | 33.59% | 1 |
|
|
2019
Q1 | $303M | Buy |
13,379,979
+1,063,450
| +9% | +$24.1M | 24.48% | 2 |
|
|
2018
Q4 | $315M | Buy |
12,316,529
+621,650
| +5% | +$15.9M | 27.26% | 2 |
|
|
2018
Q3 | $382M | Buy |
11,694,879
+481,000
| +4% | +$15.7M | 30.43% | 1 |
|
|
2018
Q2 | $254M | Buy |
11,213,879
+315,000
| +3% | +$7.14M | 30.84% | 1 |
|
|
2018
Q1 | $264M | Buy |
10,898,879
+151,771
| +1% | +$3.68M | 23.51% | 3 |
|
|
2017
Q4 | $300M | Buy |
10,747,108
+41,000
| +0.4% | +$1.14M | 20.21% | 3 |
|
|
2017
Q3 | $367M | Sell |
10,706,108
-72
| -0% | -$2.47K | 16.83% | 3 |
|
|
2017
Q2 | $427M | Buy |
10,706,180
+1,072
| +0% | +$42.7K | 15.67% | 4 |
|
|
2017
Q1 | $394M | Buy |
10,705,108
+197,500
| +2% | +$7.27M | 16.31% | 4 |
|
|
2016
Q4 | $335M | Buy |
10,507,608
+1,100,471
| +12% | +$35.1M | 16.13% | 4 |
|
|
2016
Q3 | $341M | Buy |
9,407,137
+673,500
| +8% | +$24.4M | 13.78% | 5 |
|
|
2016
Q2 | $198M | Buy |
8,733,637
+1,909,000
| +28% | +$43.3M | 9.31% | 5 |
|
|
2016
Q1 | $128M | Buy |
6,824,637
+1,763,000
| +35% | +$33.1M | 5.86% | 5 |
|
|
2015
Q4 | $83M | Buy |
5,061,637
+4,700,952
| +1,303% | +$77M | 3.56% | 5 |
|
|
2015
Q3 | $3.96M | Buy |
+360,685
| New | +$3.96M | 0.23% | 6 |
|